This inventor holds 1 USPTO granted patent. Top assignees: Merck + Co., Inc., Merck Frosst Canada & Co.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,770 
1 out of 80 Years Active: 2009
Title: The Innovative Contributions of James N Michaels
Introduction
James N Michaels is a notable inventor based in Perkasie, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on montelukast sodium. His innovative approach has led to advancements that benefit both the industry and patients.
Latest Patents
James N Michaels holds a patent for a novel polymorphic form of montelukast sodium. This invention not only provides a new polymorphic form but also includes methods of using and pharmaceutical compositions containing this novel form. Additionally, the patent covers montelukast sodium: acetonitrile solvates, which serve as intermediates in the formation of crystalline montelukast sodium.
Career Highlights
Throughout his career, James has worked with prominent companies such as Merck & Co., Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical science.
Collaborations
James has collaborated with esteemed colleagues, including Jun-Hong Chou and Michael B Gentzler. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
James N Michaels exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of montelukast sodium, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile